Biochemistry, Genetics and Molecular Biology
Single-Nucleotide Polymorphism
100%
Genetic Divergence
69%
Genetic Variation
48%
MicroRNA
44%
Case-Control Study
34%
T Cell
26%
Mitochondrial DNA
26%
Genetics
24%
Genome-Wide Association Study
20%
Telomere Length
20%
Immune Response
18%
Overall Survival
17%
Leukocyte
17%
Genetic Association
17%
Gene Polymorphism
17%
Immune Checkpoints
17%
Telomere
17%
Genomics
16%
Cancer Cell
16%
Genotyping
13%
Single Nucleotide Polymorphism
13%
Serum Total Protein
12%
Stem Cell
12%
Carcinogenesis
12%
Gene Dosage
11%
Smoking
10%
Biogenesis
9%
Expression Quantitative Trait Loci
9%
DNA Hypomethylation
8%
Response Factor
8%
Nanog
8%
Cancer Growth Factor
8%
Peripheral Blood Lymphocyte
8%
Anabolism
8%
Passive Smoking
8%
Liver Function
8%
Wnt Signaling Pathway
8%
Comorbidity
8%
Matrilysin
8%
DNA Content
8%
Mesenchymal-Epithelial Transition
8%
Blood Plasma
8%
DNA Methylation
8%
Regulator of G Protein Signalling
8%
Cohort Study
8%
Pharmacogenetics
8%
Germ Cell
8%
Germline
8%
Octamer Transcription Factor 4
8%
Signaling Protein
8%
Keyphrases
Genetic Variants
45%
Single nucleotide Polymorphism
45%
H2AX
26%
Clinical Outcomes
26%
Confidence Interval
22%
Bladder Cancer
21%
Peripheral Blood Leukocytes
19%
Localized Prostate Cancer
17%
Lung Cancer Risk
17%
Telomere
17%
Quality of Life
17%
Mitochondrial DNA Copy number
17%
Recurrence Prediction
17%
Early-stage Lung Cancer
17%
Non-muscle Invasive Bladder Cancer (NMIBC)
17%
Genetic Variation
17%
Hazard Ratio
17%
Telomere Length
16%
Biochemical Recurrence
16%
MicroRNA
16%
Tumorigenesis
15%
Physical Component Summary
14%
Ionizing Radiation
14%
Peripheral Blood Lymphocytes
12%
Radiation Effects
11%
Prognostic Value
11%
DNA Damage
11%
Odds Ratio
10%
Risk Factors
10%
Renal Cell Carcinoma
10%
Inflammation Pathway
10%
Cancer Patients
10%
Survival Prediction
9%
Transurethral Resection
9%
High Risk
9%
Recurrence Risk
9%
Peripheral Blood
9%
Relative Telomere Length
9%
Double-strand Breaks
8%
Mitochondrial DNA Variation
8%
Serum Proteins
8%
DNA Hypomethylation
8%
Systemic Inflammatory Response
8%
γH2AX
8%
Predictors of Progression
8%
Transforming Growth Factor-β
8%
Mexican Americans
8%
Physical Quality of Life
8%
Soluble Immune Checkpoint-related Protein
8%
Field Synopsis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
47%
Recurrent Disease
46%
microRNA
44%
Non Muscle Invasive Bladder Cancer
42%
Malignant Neoplasm
33%
Inflammation
21%
Biological Marker
21%
Renal Cell Carcinoma
17%
Non Small Cell Lung Cancer
17%
Colorectal Carcinoma
17%
Neoplasm
16%
Carcinogenesis
14%
Ionizing Radiation
12%
Case-Control Study
11%
Cancer Growth
10%
Circulating microRNA
9%
Colorectal Adenoma
9%
Lung Adenocarcinoma
8%
Lung Cancer
8%
microRNA 210
8%
Biochemical Recurrence
8%
Liver Cell Carcinoma
8%
Octamer Transcription Factor 4
8%
Matrilysin
8%
Mitochondrial DNA
8%
Pancreas Adenocarcinoma
8%
Tumor Necrosis Factor
8%
microRNA 155
8%
Interleukin 6
8%
Prostate Cancer
8%
Cancer Recurrence
8%
Glutathione
8%
Gastric Inhibitory Polypeptide
7%
C Peptide
7%
Matrix Metalloproteinase
7%
Diseases
6%
Adenoma
6%
Hypoxia Inducible Factor 1
5%
Vitamin D
5%
Vorinostat
5%
Polyp
5%
Overall Survival
5%
